Skip to content

Predicting Success of HFNC: The Utility of the ROX Index

Predicting Failure of High Flow Nasal Cannula in Pneumonia Patients With Hypoxemic Respiratory Failure: The Utility of ROX Index

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02834325
Enrollment
201
Registered
2016-07-15
Start date
2009-01-31
Completion date
2012-12-31
Last updated
2016-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Pneumonia

Keywords

high flow nasal cannula, success, failure, ROX index

Brief summary

The purpose of the study was to describe early predictors and to develop a prediction tool that accurately identifies the need for mechanical ventilation in pneumonia patients with acute respiratory failure treated with High Flow nasal cannula.

Detailed description

Purpose The purpose of the study is to describe early predictors and to develop a prediction tool that accurately identifies the need for mechanical ventilation (MV) in pneumonia patients with hypoxemic acute respiratory failure (ARF) treated with high-flow nasal cannula (HFNC). Materials and methods This is a 4-year prospective observational 2-center cohort study including patients with severe pneumonia treated with HFNC. High-flow nasal cannula failure was defined as need for MV. ROX index was defined as the ratio of pulse oximetry/fraction of inspired oxygen to respiratory rate.

Interventions

PROCEDUREmechanical ventilation

Sponsors

Hospital Universitari Vall d'Hebron Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of acute respiratory failure secondary to pneumonia receiving HFNC therapy

Exclusion criteria

* younger than 18 years old * indication for mechanical ventilation at ICU admission * limitation of therapeutic effort

Design outcomes

Primary

MeasureTime frameDescription
prediction of need for mechanical ventilation using ROX indexthrough study completion, an average of 1 yearparticipants will be followed during their stay in the ICU registering the days with HFNC treatment and their need or not for mechanical ventilation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026